# This Present Study Can be Used by Clinicians Who Treat Psychiatric Patients: Dentists Might Expect Xerogenic Side Effects of Specific Psychiatric Drugs Which Can Affect Dental Treatment, and the Results Can Help Psychiatrist to Choose the Less Xerogenic Psychiatric Medication

> **NCT06920472** · — · COMPLETED · sponsor: **Semmelweis University** · enrollment: 361 (actual)

## Conditions studied

- Psychiatric Disorders
- Xerostomia Due to Hyposecretion of Salivary Gland

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06920472
- **Lead sponsor:** Semmelweis University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-01
- **Primary completion:** 2018-01-01
- **Final completion:** 2018-01-01
- **Target enrollment:** 361 (ACTUAL)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06920472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06920472, "This Present Study Can be Used by Clinicians Who Treat Psychiatric Patients: Dentists Might Expect Xerogenic Side Effects of Specific Psychiatric Drugs Which Can Affect Dental Treatment, and the Results Can Help Psychiatrist to Choose the Less Xerogenic Psychiatric Medication". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06920472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*